Bio-Rad Laboratories, Inc.
BIO
Xếp hạng trong cổ phiếu
#2168
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Giá cổ phiếu
$352.89
Đồng bộ lần cuối: 2026-10-16
Vốn hóa thị trường
$9.44B
Thay đổi (1 ngày)
-3.34%
Thay đổi (1 năm)
13.83%
Quốc gia
US
Giao dịch Bio-Rad Laboratories, Inc. (BIO)
Danh mục
Healthcare
EPS của Bio-Rad Laboratories, Inc. (BIO)
EPS tính đến June 2026 TTM: $8.33
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của Bio-Rad Laboratories, Inc., EPS hiện tại của công ty (TTM) là $8.33. Vào cuối năm 2024, công ty có EPS là $-65.36, tăng so với EPS năm 2023 là $-21.82.
Lịch sử EPS của Bio-Rad Laboratories, Inc. từ 2000 đến 2026
EPS vào cuối mỗi năm
| Năm | EPS | Thay đổi |
|---|---|---|
| 2026 (TTM) | $8.33 | -70.11% |
| 2025 | $27.87 | -142.64% |
| 2024 | $-65.36 | 199.54% |
| 2023 | $-21.82 | -82.08% |
| 2022 | $-121.79 | -185.40% |
| 2021 | $142.61 | 11.54% |
| 2020 | $127.86 | 116.97% |
| 2019 | $58.93 | 387.02% |
| 2018 | $12.10 | 193.69% |
| 2017 | $4.12 | 368.18% |
| 2016 | $0.88 | -76.47% |
| 2015 | $3.74 | 21.43% |
| 2014 | $3.08 | 13.24% |
| 2013 | $2.72 | -53.50% |
| 2012 | $5.85 | -8.45% |
| 2011 | $6.39 | -4.63% |
| 2010 | $6.70 | 26.89% |
| 2009 | $5.28 | 60.00% |
| 2008 | $3.30 | -5.17% |
| 2007 | $3.48 | -11.22% |
| 2006 | $3.92 | 25.24% |
| 2005 | $3.13 | 18.11% |
| 2004 | $2.65 | -11.67% |
| 2003 | $3.00 | 11.11% |
| 2002 | $2.70 | 50.84% |
| 2001 | $1.79 | 40.94% |
| 2000 | $1.27 | 0.00% |
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
| Công ty | EPS | Chênh lệch EPS | Quốc gia |
|---|---|---|---|
| $3.11 | -62.67% |
US
|
|
| $3.59 | -56.90% |
IE
|
|
| $9.73 | 16.81% |
US
|
|
| $2.48 | -70.23% |
US
|
|
| - | - |
DE
|
